Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEVICE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 63 adverse event reports in the FDA FAERS database where DEVICE was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for DEVICE

Side Effect Reports % Deaths Hosp.
Blood glucose increased 2,114 16.6% 5 161
Device issue 1,417 11.1% 7 85
Product use issue 1,076 8.4% 5 94
Intercepted product preparation error 1,033 8.1% 1 1
Wrong technique in product usage process 935 7.3% 1 25
Device leakage 795 6.2% 0 9
Injection site pain 751 5.9% 1 40
Syringe issue 634 5.0% 0 1
Product quality issue 567 4.5% 2 9
Drug ineffective 488 3.8% 22 94
Dyspnoea 482 3.8% 28 135
Cough 458 3.6% 15 58
Off label use 443 3.5% 22 63
Visual impairment 437 3.4% 5 31
Device use issue 396 3.1% 0 24

Other Indications for DEVICE

Type 2 diabetes mellitus (3,625) Product used for unknown indication (942) Prostate cancer (852) Diabetes mellitus (660) Type 1 diabetes mellitus (495) Dyslipidaemia (172) Keratoconus (139) Multiple sclerosis (104) Precocious puberty (103) Dermatitis atopic (89)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

DEVICE Full Profile All Relapsing-remitting multiple sclerosis Drugs DEVICE Demographics DEVICE Timeline